Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
207
NCT01520116
Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 31, 2012
Completion: Not specified
NCT01668524
ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects
Phase: Phase 2
Start: Aug 31, 2012
Completion: Aug 31, 2012
NCT05728593
The Effect of Parent-based Occupational Therapy
Phase: N/A
Role: Collaborator
Start: Feb 1, 2021
Completion: Dec 1, 2022